推荐产品
描述
anionic
质量水平
方案
≥98%
分子量
521.69 g/mol (anhydrous basis)
应用
detection
SMILES字符串
O.[Na+].C[C@H](CCC(=O)NCCS([O-])(=O)=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
InChI
1S/C26H45NO6S.Na.H2O/c1-16(4-7-24(30)27-12-13-34(31,32)33)19-5-6-20-18-15-23(29)22-14-17(28)8-10-26(22,3)21(18)9-11-25(19,20)2;;/h16-23,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33);;1H2/q;+1;/p-1/t16-,17-,18+,19-,20+,21+,22+,23+,25-,26-;;/m1../s1
InChI key
MJKUJELEPWZEGU-IGEKTTBWSA-M
一般描述
牛磺猪去氧胆酸钠水合物是牛磺酸酰胺化胆盐,可作为阴离子洗涤剂。
应用
牛磺猪去氧胆酸钠水合物已用于一项研究,以评估呋喃处理大鼠肝脏中细胞毒性、再生性细胞增殖和继发性氧化 DNA 损伤的剂量响应数据。 它也被用于一项研究,以探讨使用固定化人工膜 HPLC 柱预测胆盐-膜相互作用。
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Arzneimittel-Forschung, 43(8), 877-880 (1993-08-01)
In this study we investigated the anticholelithogenic and choleretic activities and the general pharmacological action of taurohyodeoxycholic acid (THDCA, Io, Praxis, CAS 2958-04-5), a new biliary acid advocated for use as anticholelithogenic agent. THDCA had no significant activity on the
Scandinavian journal of gastroenterology, 36(9), 981-986 (2001-08-28)
Tauro-hyodeoxycholic acid is a hydrophilic bile acid of potential interest for treating cholestatic liver diseases. Bile acid pool is enriched with this bile acid during acute administration in patients with interrupted enterohepatic circulation. The aim of our study was to
Functional and proliferative effects of repeated low-dose oral administration of furan in rat liver.
Molecular nutrition & food research, 54(11), 1556-1567 (2010-06-12)
Furan, a food contaminant formed during heat processing, induces hepatocellular tumors in rodents and high incidences of cholangiocarcinomas in rats even at the lowest dose (2 mg/kg b.w.) administered. Initial estimates suggested that human intake of furan may be as
Arzneimittel-Forschung, 43(8), 888-893 (1993-08-01)
Fifty-two-week oral toxicity and 24-week intramuscular toxicity of a new synthetized biliary acid, taurohyodeoxycholic acid (Io, Praxis, CAS 2958-04-5) were investigated in dogs. Taurohyodeoxycholic acid was orally administered at dose levels up to 500 mg/kg/d and i.m. administered at dose
The Italian journal of gastroenterology, 28(7), 391-392 (1996-09-01)
Taurohyodeoxycholic acid and tauroursodeoxycholic acid were infused intraduodenally at a rate of 0.8 g/h for three hours in 3 cholecystectomized T-tube patients. Biliary lipid secretion and bile acid composition were evaluated before and after replacement of the endogenous bile acid
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门